In accordance with the findings of the above-mentioned researchers, our findings suggest that lower adiponectin values during the second trimester and prepartum period in patients GDM are due to the greater BMI, greater adiposity, and, in consequence, the greater insulin resistance of these patients and the subsequent alteration of adiponectin homeostasis. Here, ADIPOQ is linked to Insulin resistance.